The antiserum was produced against synthesized peptide derived from human p44/42 MAP Kinase.
WBELISA
HumanMouseRat
Western blot analysis of extracts from 293 cells, treated with EGF 200 ng/ml 30', using p44/42 MAP Kinase (Ab-202) Antibody. The lane on the right is treated with the synthesized peptide
滬公網(wǎng)安備 31011702004356號(hào)